Skip to content

Childhood Sarcoma With Bcor Genetic Alterations C5708183

Published: July 22, 2026Updated: August 25, 2026

A rare, aggressive sarcoma in children linked to changes in the BCOR gene. It requires multidisciplinary treatment including chemotherapy and surgery.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
C80.1
ICD-11
2A00.0
Body system
oncologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Fever

Abdominal pain

(gastrointestinal)

Generalized symptoms

(oncologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Weight loss

(constitutional)

Elevated lactate dehydrogenase

(laboratory)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Complete Surgical Resection

Surgical removal of the tumor with wide margins when anatomically feasible. Complete resection remains the cornerstone of curative intent for localized childhood sarcomas with BCOR alterations.

surgical
2

Drug therapy and clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Multi-Agent Chemotherapy Protocol

Systemic chemotherapy using combination regimens typically including agents such as vincristine, dactinomycin, cyclophosphamide, doxorubicin, and ifosfamide. Given as neoadjuvant and/or adjuvant therapy to address microscopic disease.

procedure

Additional treatment options

Radiation Therapy

Focused radiation therapy to the tumor bed, particularly for tumors with positive margins or high-risk features. Helps reduce local recurrence risk in residual disease.

procedure

Rehabilitative Physical Therapy

Specialized physical therapy to maintain limb function, manage scar tissue, and restore mobility following surgery or radiation treatment. Includes strengthening exercises and range of motion activities.

physical_therapy

Psychosocial Support Program

Comprehensive psychological support including counseling for the child and family, addressing anxiety, depression, trauma, and adjustment to cancer diagnosis and treatment side effects.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Childhood Sarcoma With Bcor Genetic Alterations C5708183?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Kao YC, Huang SC, Antonescu CR. BCOR-altered sarcomas: emerging entities and clinicopathological correlations. Mod Pathol. 2022;35(2):178-187.

review2022
2

WHO Classification of Tumours Editorial Board. WHO Classification of Soft Tissue and Bone Tumours. Lyon: IARC Press; 2020.

guideline2020
3

Puls F, Niblett AJ, Mangham DC, Sumathi VP, McCauley J, Roberts S, et al. BCOR-CCNB3 sarcoma: a novel entity in the expanding family of Ewing-like primitive round cell mesenchymal tumors. Histopathology. 2021;78(6):862-872.

other2021
4

Yoshida A, Arai Y, Kobayashi E, Taniguchi H, Iwata S, Sonoda K, et al. Clinicopathological impact of BCOR expression in sarcoma with BCOR genetic alteration. Cancer Sci. 2023;114(5):2032-2041.

clinical_trial2023

Medication Comparisons

Compare medications used to treat Childhood Sarcoma With Bcor Genetic Alterations C5708183. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy